Filter
505
Filtered Results: 505
Text search:
Instituto
Nacional
de
Salud
Colombia
Featured
Recommendations
35
New Publications
109
Language
Document type
No document type
228
Studies & Reports
121
Guidelines
81
Strategic & Response Plan
27
Manuals
20
Training Material
12
Fact sheets
11
Situation Updates
2
Resource Platforms
2
App
1
Countries / Regions
Latin America and the Carribbean
99
Colombia
78
Venezuela
42
Paraguay
16
Global
15
Peru
12
Argentina
10
Brazil
10
Bolivia
9
Ecuador
7
El Salvador
4
Chile
3
Mozambique
3
Haiti
3
North America
3
Ukraine
2
Guinea-Bissau
2
Bangladesh
2
South Africa
2
Uganda
2
Ethiopia
2
Angola
2
Tajikistan
1
Nepal
1
Thailand
1
Rwanda
1
Kazakhstan
1
Cameroon
1
Syria
1
Kyrgyzstan
1
Burkina Faso
1
Asia
1
Uruguay
1
Eastern Europe
1
Russia
1
Zambia
1
South Sudan
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
209
Clinical Guidelines
45
Women & Child Health
45
Public Health
43
Capacity Building
13
Key Resources
5
Pharmacy & Technologies
3
Toolboxes
Mental Health
64
COVID-19
61
TB
57
NTDs
28
HIV
24
Planetary Health
18
Disability
17
Rapid Response
12
Zika
12
Caregiver
10
Refugee
9
AMR
9
Global Health Education
8
Pharmacy
6
NCDs
6
Conflict
4
Natural Hazards
3
Health Financing Toolbox
3
Ebola
1
Typhoon
1
Primary health care offers a cost–effective route to achieving universal health coverage (UHC). However, primary health-care systems are weak in many low- and middle-income countries and often fail to provide comprehensive, people-centred, integrated care. We analysed the primar...
The chapter Fostering Health Systems’ Monitoring to Better Serve Older Populations is part of the publication series entitled Decade of Healthy Aging: Situation and Challenges. The publications are designed to favor the prioritization of effective actions at the local level as well as the monitori...
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet...
The chapter Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time, is part of the publication series titled “Decade of Healthy Aging: situation and challenges”. This document aims to provide an outline of the current situation in Latin America and the C...
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.
As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training of health-care providers training manual) to support implementation of the mhGAP Intervention Guide for mental, neurological and substance use (MNS...
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m...
This report summarizes the latest scientific knowledge on the links between exposure to air pollution and adverse health effects in children. It is intended to inform and motivate individual and collective action by health care professionals to prevent damage to children’s health from exposure to ...
This report provides insights into the prevalence of belief systems and gender norms among young women and men in the region. It looks in depth at the most entrenched beliefs and behaviours among the younger population and provides ample evidence that we must challenge and change the prevailing beli...
Every year, an estimated 15 million babies are born preterm – before 37 weeks of pregnancy. That is more than 1 in 10 live births. Approximately 1 million children die each year worldwide due to complications from their early birth. Those that survive often face a lifetime of ill-health including ...
